FPH.NZ - Fisher & Paykel Healthcare Corporation Limited

NZSE - NZSE Delayed price. Currency in NZD
15.26
-0.04 (-0.26%)
At close: 4:59PM NZST
Stock chart is not supported by your current browser
Previous close15.30
Open15.25
Bid15.05 x 485800
Ask15.30 x 241000
Day's range15.00 - 15.32
52-week range11.92 - 16.44
Volume706,521
Avg. volume668,541
Market cap8.734B
Beta1.68
PE ratio (TTM)46.24
EPS (TTM)0.33
Earnings date26 Nov 2018
Forward dividend & yield0.25 (1.65%)
Ex-dividend date2018-06-21
1y target est12.79
  • Why Fundamental Investors Might Love Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH)
    Simply Wall St.3 days ago

    Why Fundamental Investors Might Love Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH)

    I’ve been keeping an eye on Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) because I’m attracted to its fundamentals. Looking at the company as a whole, as a potential stockRead More...

  • Is Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) Attractive At Its Current PE Ratio?
    Simply Wall St.22 days ago

    Is Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) Attractive At Its Current PE Ratio?

    This analysis is intended to introduce important early concepts to people who are starting to invest and want to begin learning about how to value company based on its currentRead More...

  • Top Growth Stocks To Buy Today
    Simply Wall St.3 months ago

    Top Growth Stocks To Buy Today

    Robust, high-growth companies such as NZX are appealing to investors for many reasons. They bring about a strong upside to your portfolio, and less downside risk as opposed to financiallyRead More...

  • June Fundamental Stock Pick: Fisher & Paykel Healthcare Corporation Limited (NZE:FPH)
    Simply Wall St.3 months ago

    June Fundamental Stock Pick: Fisher & Paykel Healthcare Corporation Limited (NZE:FPH)

    Building up an investment case requires looking at a stock holistically. Today I’ve chosen to put the spotlight on Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) due to its excellentRead More...

  • AAP10 months ago

    Fisher & Paykel wins patent court case

    Fisher & Paykel Healthcare has won a patent case against rival medical products manufacturer ResMed, after a court in the United Kingdom ruled the patent claim invalid. In 2016, New Zealand-based Fisher & Paykel sought a declaration from the High Court that three of ResMed's European patents were invalid in the UK and should be revoked. ResMed revoked two of its patents in the UK just before the trial was due to start, but left one for consideration by the High Court's patents division.